Search clinical trials for: ToleroMune Ragweed

Total 75 results

Circassia Limited
Cetero Research, San Antonio; Adiga Life Sciences, Inc.

Completed

ToleroMune Ragweed Follow up Study

Rhinoconjunctivitis | Ragweed Allergy

Canada
Circassia Limited
Cetero Research, San Antonio; Adiga Life Sciences, Inc.

Completed

ToleroMune Ragweed Exposure Chamber Study

Ragweed Allergy

Canada
Circassia Limited
Cetero Research, San Antonio; Adiga Life Sciences, Inc.

Completed

Identification of Potential Biomarkers of Response to Peptide Immunotherapy for Ragweed Allergy

Ragweed Allergy

Canada
Circassia Limited
Adiga Life Sciences, Inc.

Completed

Safety of ToleroMune Ragweed to Treat Ragweed Allergy in Ragweed Allergic Subjects With Rhinoconjunctivitis

Allergy

Canada
Fraunhofer-Institute of Toxicology and Experimental...

Recruiting

Threshold Concentrations for Ragweed and Birch Pollen in Seasonal Allergic Rhinitis (UBAMBI)

Allergic Rhinitis | Seasonal Allergic Rhinitis | Birch Pollen Allergy | Ragweed Allergy

Germany
Aldeyra Therapeutics, Inc.

Completed

A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis

Allergic Conjunctivitis | Seasonal Allergies

Canada
Clinique Spécialisée en Allergies de la Capitale
ALK-Abelló A/S

Completed

Vestibular Versus Sublingual Route of AIT Tablets

Hypersensitivity

Canada
Virginia Commonwealth University

Terminated

Desensitization and Cross-Desensitization During Oral Grass or Ragweed Pollen Immunotherapy

Immunologic Desensitization

United States
Lawson Health Research Institute
Ontario Ministry of Agriculture, Food and Rural Affairs

Completed

The Anti-allergic Effects of Specific Probiotics

Allergic Rhinitis

Canada
Allergy Therapeutics

Withdrawn

Evaluation of Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL (Monophosphoryl Lipid A)

Type I Hypersensitivity

Canada
Allergy Therapeutics

Completed

Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick Test

Type I Hypersensitivity

United States
University of Wisconsin, Madison
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Completed

AsthMatic Inflammation and Neurocircuitry Activation (MINA) (MINA)

Allergic Asthma

United States
Novartis Pharmaceuticals

Completed

Safety, Tolerability and Pharmacokinetics of Multiple Doses of VAK694 in Atopic Subjects With Seasonal Rhinitis

Allergic Rhinitis

United States, Canada
Bausch & Lomb Incorporated

Completed

Safety, Pharmacokinetics, and Efficacy of Bepotastine Besilate Nasal Product After Ragweed Pollen Exposure in an Environmental Chamber

Seasonal Allergic Rhinitis

United States
Cuneyt M. Alper
National Institute on Deafness and Other Communication Disorders (NIDCD)

Completed

TransMEM Gas Exchange -- Project 1, Aim 2

Middle Ear Disease | Nasal Allergy

United States
University of Maryland, Baltimore
National Institute of Mental Health (NIMH)

Completed

Examining the Link Between Depression and Seasonal Allergies

Depression

United States
Merck Sharp & Dohme LLC

Completed

Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)

Rhinitis, Allergic, Seasonal
HAL Allergy

Completed

HAL-MRE1 Subcutaneous Immunotherapy in Ragweed Allergic Patients First-in-human

Rhinitis, Allergic | Rhinoconjunctivitis, Allergic

Canada
Dynavax Technologies Corporation

Completed

An Evaluation of the Efficacy and Safety of TOLAMBA™ for Ragweed-Allergic Rhinitis in an Environmental Exposure Chamber

Rhinitis, Allergic, Seasonal

Canada
Dynavax Technologies Corporation

Terminated

Efficacy and Safety Study of TOLAMBA™ in Ragweed-Allergic Adults

Rhinitis, Allergic, Seasonal

United States
Adiga Life Sciences, Inc.
Circassia Limited

Terminated

Observational Analysis of T Cell Responses to SPIREs for Multiple Allergens in Subjects With Allergy in North America

Allergy

United States
Faes Farma, S.A.
Allied Research International

Completed

PK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the Symptoms of SAR in an EEC Model (5-arm)

Seasonal Allergic Rhinitis | Hay Fever | Rhinoconjunctivitis

Canada
Johns Hopkins University

Completed

DNA Vaccine for Ragweed Allergic Adults

Seasonal Allergic Rhinitis

United States
National Institute of Allergy and Infectious Diseases...
Circassia Limited

Completed

A Randomized Prospective Clinical Trial of Fel d 1 Peptide Immunotherapy

Cat Allergy | Cat Hypersensitivity

Canada
UCB Pharma

Completed

A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen

Rhinitis | Allergic | Seasonal

Canada
UCB S.A. - Pharma Sector

Completed

Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing Seasonal Allergic Rhinitis (SAR) Symptoms in Ragweed Sensitive Subjects

Rhinitis, Allergic, Seasonal

Canada
The University of Texas Medical Branch, Galveston

Completed

Innate Neutrophilic Nasal Inflammation in a Pollen Exposure Chamber (Pollen)

Allergic Rhinitis
Woodmont Pharmaceuticals, Inc.
ORA, Inc.

Terminated

Study Evaluating Safety of Ragweed Mix Given by Intralymphatic Node Injections

Allergic Rhinitis | Allergic Conjunctivitis

United States
ALK-Abelló A/S

Completed

Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (P08607, MK-3641-006)

Rhinitis, Allergic, Seasonal
ALK-Abelló A/S

Completed

Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05233)(COMPLETED)

Conjunctivitis | Rhinitis; Allergic, With Asthma
ALK-Abelló A/S

Completed

Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05234)

Rhinitis, Allergic | Conjunctivitis
ALK-Abelló A/S

Completed

Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081)

Allergy | Rhinitis | Conjunctivitis | Rhinoconjunctivitis
ALK-Abelló A/S

Completed

A Study of Ragweed (Ambrosia Artemisiifolia) Allergy Immunotherapy Tablet in Adults With Ragweed Allergies (P05751)

Allergy
GlaxoSmithKline

Completed

Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine

Rhinitis, Allergic, Seasonal

United States
Circassia Limited
Quintiles, Inc.; Adiga Life Sciences, Inc.

Completed

Birch-SPIRE Safety and Efficacy Study

Rhinitis

Canada
National Institute of Allergy and Infectious Diseases...
Immune Tolerance Network (ITN)

Completed

Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies

Hypersensitivity | Allergy | Rhinitis | Hay Fever

United States
GlaxoSmithKline

Completed

Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of Action

Rhinitis, Allergic, Seasonal

United States
Circassia Limited
Adiga Life Sciences, Inc.

Completed

Ragweed-SPIRE Follow-On Study

Rhinoconjunctivitis | Ragweed Allergy

Canada
University of Utah
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)

Heart Diseases | Cardiovascular Diseases | Arrhythmia | Ventricular Fibrillation | Tachycardia, Ventricular | Death, Sudden, Cardiac | Ventricular Arrhythmia
Alcon Research

Completed

Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis

Allergic Conjunctivitis
Circassia Limited
Adiga Life Sciences, Inc.

Completed

Evaluating the Efficacy of Ragweed-SPIRE Following Exposure to Ragweed Allergen in an Environmental Exposure Chamber

Seasonal Allergic Rhinitis

Canada
Greer Laboratories

Completed

Efficacy and Safety Study Of Short Ragweed Pollen Sublingual-Oral Immunotherapy

Allergy

United States
Circassia Limited
Adiga Life Sciences, Inc.

Completed

Safety Study of Ragweed-SPIRE in Subjects With Ragweed Allergies and Asthma

Asthma | Seasonal Allergic Rhinitis

Canada
Greer Laboratories

Completed

Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies

Allergic Rhinitis

United States
Circassia Limited
Adiga Life Sciences, Inc.

Completed

ToleroMune Grass Follow on Study

Grass Allergy | Rhinoconjunctivitis

Canada
Circassia Limited
Adiga Life Sciences, Inc.

Completed

ToleroMune House Dust Mite (HDM) Tolerability Study

Rhinoconjunctivitis

Canada
Circassia Limited
Adiga Life Sciences, Inc.; Topstone Research

Completed

An Optional Investigation of Biomarkers of Efficacy

Rhinoconjunctivitis

Canada
Circassia Limited
Adiga Life Sciences, Inc.; Inflamax Research Incorporated

Completed

ToleroMune House Dust Mite Follow on Study

Rhinoconjunctivitis | House Dust Mite Allergy
Mylan Pharmaceuticals Inc

Completed

A Comparison of Mometasone Nasal Spray, Nasonex Nasal Spray, Nasonex Nasal Spray Suspension, & Placebo for Treatment of Seasonal Allergies for Safety, Efficacy, & Superiority in 1520 Male & Female Volunteers

Treatment of the Signs and Symptoms of Seasonal Allergic Rhinitis
Antigen Laboratories, Inc.

Withdrawn

Phase 2 Study in Adults Sensitized to Short Ragweed

Allergic Rhinitis

Search clinical trials for: ToleroMune Ragweed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations